Scarica l'app Stockscreener
0.1518
1.88%
0.0028
Dopo l'orario di chiusura:
.15
-0.0018
-1.19%
Precedente Chiudi:
$0.149
Aprire:
$0.1519
Volume 24 ore:
651.67K
Relative Volume:
0.05
Capitalizzazione di mercato:
$3.05M
Reddito:
$19.57M
Utile/perdita netta:
$-25.12M
Rapporto P/E:
-0.0657
EPS:
-2.3114
Flusso di cassa netto:
$-19.71M
1 W Prestazione:
+7.89%
1M Prestazione:
-12.10%
6M Prestazione:
-88.50%
1 anno Prestazione:
-95.26%
Intervallo 1D:
$0.147
$0.1554
Intervallo di 1 settimana:
$0.1289
$0.1556
Portata 52W:
$0.1289
$3.42
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Nome
Vivos Therapeutics Inc
Settore
Industria
Telefono
(866)908-4867
Indirizzo
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
0.1518 | 2.83M | 19.57M | -25.12M | -19.71M | -2.3114 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Vivos Therapeutics Inc Borsa (VVOS) Ultime notizie
Vivos Therapeutics Switches Auditors, Dismisses Baker Tilly - Minichart
Vivos TherapeuticsAudit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern - TradingView
Vivos Therapeutics Targets $3.6 Million in Annual Cost Reductions as Revenue Growth Initiatives Accelerate - Yahoo Finance
Vivos Therapeutics plans $3.6M annual cost reduction - Investing.com
Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives - The Manila Times
Referrals to Vivos’ Las Vegas sleep centers rose about threefold. Added revenue is expected in Q4. - Stock Titan
Form 4 Vivos Therapeutics Inc For: 28 September By Investing.com - Investing.com South Africa
Vivos Therapeutics Inc (VVOS) Stock Price Target & Forecast - TradingKey
Director at Vivos Therapeutics (VVOS) receives 12,000 stock options - Stock Titan
[Form 4] Vivos Therapeutics, Inc. Insider Trading Activity - Stock Titan
Vivos Therapeutics Inc. (VVOS) Key Financial Ratios – Valuation, Profitability & More - Value Research
Vivos Issues 11.45M Shares to Retire $2.86M of Debt in Dilutive Exchange - Minichart
Vivos exchanges $2.9m debt for common stock with Streeterville By Investing.com - Investing.com Nigeria
Vivos to Issue 11.4M Shares to Settle $2.86M in Debt - minichart.com.sg
Vivos exchanges $2.9m debt for common stock with Streeterville - Investing.com India
Vivos Therapeutics Announces Material Debt Reduction - The Manila Times
Vivos Therapeutics Swaps $2.86M of Streeterville Debt for Up to 11.45M Shares - TradingView
Vivos Therapeutics Inc (NASDAQ: VVOS) Share Price, VVOS Stock News, VVOS Share Price & Updates - Kalkine
Vivos Therapeutics Inc. (VVOS) Peer Comparison – Compare with Others - Value Research
Vivos Therapeutics (VVOS) investor lists 122,963 shares, under 5% - Stock Titan
Regional Sleep & Airway Medicine Center to Be Established in Palm Beach County, Fla - Sleep Review
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference - marketscreener.com
Vivos Therapeutics Inc. (VVOS) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Vivos Therapeutics Surges as Investors Weigh Nevada Growth Updates and Florida Expansion Plan - Moomoo
Vivos Therapeutics Inc. (VVOS) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center - The Manila Times
Vivos Therapeutics partners with Florida cardiology group for sleep center - Investing.com
Vivos Therapeutics partners with Florida cardiology group for sleep center By Investing.com - Investing.com UK
Vivos Therapeutics (VVOS) grants 250K shares, 150K options - Stock Titan
Vivos Therapeutics reports 212% rise in Nevada patient referrals By Investing.com - Investing.com Canada
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers - Barchart.com
Vivos Therapeutics Reports 212% Increase in Nevada Sleep & Airway Medicine Center Referrals Ahead of Henderson Facility Opening - Quiver Quantitative
Vivos Therapeutics Inc (VVOS) Stock News Today - TradingKey
Vivos Therapeutics opens Henderson facility with $10M capacity - Investing.com
Vivos Therapeutics Opens Nevada Sleep Treatment Center - marketscreener.com
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment - The Manila Times
Vivos Therapeutics opens Henderson facility with $10M capacity By Investing.com - Investing.com Canada
Vivos Therapeutics Opens New Henderson Sleep Center, Expects Capacity to More Than Double to Over $10 Million Annually - Moomoo
Vivos expects its Nevada sleep center to more than double annual capacity to $10M+ - Stock Titan
Vivos Therapeutics Inc (VVOS) (Q2 2026) Earnings Call Highlights: Revenue Surges 35% on ... By GuruFocus - Investing.com Canada
Vivos Therapeutics shares slide after Q2 revenue falls short of forecasts - Yahoo Finance
Vivos Therapeutics stock falls 6% on second quarter revenue miss By Investing.com - Investing.com Canada
Vivos Therapeutics stock falls 6% on second quarter revenue miss - Investing.com
Conferencia de resultados del 2T de 2026 de Vivos Therapeutics (VVOS): los ingresos suben un 35%, persisten los riesgos de liquidez - TradingKey
Vivos Therapeutics (VVOS) Q2 2026 Earnings Call: Umsatz steigt um 35 %, Liquiditätsrisiken bestehen weiterhin - TradingKey
Vivos Therapeutics partners with SPCVA to form AIM Florida - scanx.trade
Vivos Therapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Vivos Therapeutics Q2 2026 Earnings Call Transcript - MarketBeat
Vivos gets Washington license to manufacture IsoPet - scanx.trade
Vivos Therapeutics reports 35% revenue increase in Q2 2026 - Investing.com India
Vivos Therapeutics Inc Azioni (VVOS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):